NovalGen Ltd.: Clinical Trials

1 trial sponsored by NovalGen Ltd., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Unknown 1

Follow NovalGen Ltd.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
First in Human Study of NVG-111 in Relapsed/Refractory ROR1+ Malignancies
NVG-111 - Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma
Phase 1UnknownNovalGen Ltd.902021-05-142023-07-07

Conditions studied

Carcinoma, Non-Small-Cell Lung (1)  ·  Leukemia, B-Cell (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Lymphoma, Follicular (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Lymphoma, Mantle-Cell (1)  ·  Melanoma (1)

Countries

United Kingdom (1)

Top investigators

Parag Jasani, MBBS, FRCP, FRCPath (1)